Greg Cohen
Impact in
-
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
-
- Liver Diseases and Immunity
Papers in
-
- Genetic factors in colorectal cancer 4
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Cancer-related Molecular Pathways 1
- Co-authors
- Marc Bissonnette (7 shared papers)Loren Joseph (7 shared papers)Sharad Khare (6 shared papers)Marion MacFarlane (2 shared papers)Howard O. Fearnhead (1 shared paper)Chris J. Norbury (1 shared paper)John Hart (5 shared papers)Ramesh K. Wali (4 shared papers)
- Journals
- Cancer Research (2 papers)Nutrition and Cancer (1 paper)European Journal of Cancer (1 paper)Inflammatory Bowel Diseases (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Greg Cohen
10 papers receiving 363 citations
Peers
Comparison fields: 5 of 57
- Oncology 193
- Hepatology 40
- Pathology and Forensic Medicine 59
- Pharmacology 51
- Cancer Research 43
Countries citing papers authored by Greg Cohen
This map shows the geographic impact of Greg Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Cohen more than expected).
Fields of papers citing papers by Greg Cohen
This network shows the impact of papers produced by Greg Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Cohen. The network helps show where Greg Cohen may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. | 2002 | 75 |
| 2 | 1994 | 62 | |
| 3 | Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. | 2003 | 52 |
| 4 | 2007 | 47 | |
| 5 | 2006 | 45 | |
| 6 | 2008 | 44 | |
| 7 | 2013 | 39 | |
| 8 | 1999 | 3 | |
| 9 | Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer | 2002 | 2 |
| 10 | 2003 | 1 |
About Greg Cohen
Greg Cohen is a scholar working on Pathology and Forensic Medicine, Oncology, Surgery, Molecular Biology and Genetics, having authored 10 papers that have together received 370 indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Inflammatory mediators and NSAID effects (2 papers), Mycobacterium research and diagnosis (1 paper), Inflammatory Bowel Disease (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (193 citations), Hepatology (40 citations), Pathology and Forensic Medicine (59 citations), Pharmacology (51 citations) and Cancer Research (43 citations). Greg Cohen has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc Bissonnette, Loren Joseph, Sharad Khare, Marion MacFarlane, Howard O. Fearnhead, Chris J. Norbury, John Hart, Ramesh K. Wali, Sandra Cerda and Michael D. Sitrin. Their work appears in journals such as Cancer Research, Nutrition and Cancer, European Journal of Cancer, Inflammatory Bowel Diseases and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.